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RESUMO
Introdução: Este estudo explora relações entre o cortisol em crianças obesas e o estado mental dos pais, o funcionamento familiar e 
os sintomas de ansiedade e depressão das crianças. 
Material e Métodos: Uma amostra de conveniência de 104 crianças obesas (55 rapazes), com idade média de 10,9 anos (desvio pa-
drão 1,76), foi recrutada numa consulta de obesidade infantil. A obesidade foi definida pelo índice de massa corporal acima do percentil 
95 ajustado para idade e sexo. Foram medidos biomarcadores neuroendócrinos. Os sintomas de ansiedade e depressão foram avali-
ados com auto e hetero-questionários (Anxiety, Depression and Stress Scales; Child Behaviour Checklist). O funcionamento familiar 
foi avaliado através de questionários aos pais (Family Adaptation and Cohesion Scales -III).
Resultados: Observou-se uma correlação negativa significativa (rs = -0,779; p = 0,003) entre o cortisol das raparigas de famílias fun-
cionais e os sintomas parentais de ansiedade. Os sintomas internalizantes relatados pelos pais (mas não os auto-relatados) são mais 
intensos nos rapazes. Não foi encontrada associação entre o cortisol das crianças e os sintomas depressivos dos pais.
Discussão: Não é possível assegurar se a associação entre cortisol sérico nas crianças obesas e sintomas de ansiedade parental se 
restringe a raparigas de famílias funcionais ou se deve a limitações do estudo. Os achados sugerem uma associação específica entre 
o cortisol sérico nas crianças obesas e a ansiedade parental. 
Conclusão: É importante considerar o género, o funcionamento familiar, o estado mental dos pais ao investigar as associações entre 
biomarcadores neuroendócrinos em crianças obesas e sintomas de ansiedade e depressão.
Palavras-chave: Ansiedade; Biomarcadores; Criança; Obesidade Pediátrica; Sistema Hipófise-Suprarrenal; Sistema Hipotálamo-
Hipofisário; Stress Psicológico
ABSTRACT
Introduction: This observational study explores potential links between obese children’s cortisol, and parental mental state, family 
functioning, and the children’s symptoms of anxiety and depression.
Material and Methods: A non-random sample of 104 obese children (55 boys), mean age 10.9 years (standard deviation 1.76), was 
recruited from a childhood obesity clinic. Obesity was defined as body mass index above the 95th age- and gender-specific percentiles. 
Neuroendocrine biomarkers were measured. Symptoms of anxiety and depression were assessed with self and parent-reported ques-
tionnaires (Anxiety, Depression and Stress Scales; Child Behaviour Checklist). Family functioning was assessed with parent-reported 
questionnaires (Family Adaptation and Cohesion Scales-III). 
Results: A significant, negative correlation (rs = -0.779; p = 0.003) between girls’ cortisol and their parents’ anxiety symptoms was 
found, limited to high functioning families. Boys scored significantly higher than girls on parent-reported internalizing symptoms but not 
on self-report. No association was found between cortisol in children and parental depressive symptoms.
Discussion: Whether the association between cortisol levels in obese children and parental mental health is effectively restricted to 
girls from high functioning families or is due to study limitations, requires further research. The lack of associations between cortisol in 
children and parental depressive symptoms, suggests a specific association between cortisol and parental anxiety symptoms. 
Conclusion: These results highlight the importance of taking into account family functioning, parental mental state and gender, when 
investigating neuroendocrine biomarkers in obese children associated with symptoms of anxiety and depression. 
Keywords: Anxiety; Biomarkers; Child; Hypothalamo-Hypophyseal System; Pediatric Obesity; Pituitary-Adrenal System; Stress Psy-
chological
INTRODUCTION
 Symptoms of anxiety and depression are frequent in 
obese children,1 especially in girls, who in addition have 
metabolic risk.1-3 Anxiety, depression and obesity are 
recognized burdens in both human and economic terms, 
therefore, it is important to investigate the aetiological 
mechanisms involved.4 Mental disorders, such as anxiety 
and depression, produce decrements in public health that 
are equivalent to those of other chronic physical diseases 
(e.g., angina, arthritis, asthma, and diabetes).4 However, 
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it is not generally acknowledged that, when mental disorders 
coexist with these physical diseases, the decrease in public 
health scores is substantially greater than when they occur 
alone. Thus, a crucial implication follows, that primary 
health care providers should not ignore the presence of 
depression and/or anxiety disorders when treating patients 
with a chronic physical disease.5
 Metabolic syndrome, of which obesity is a part, shares 
risk factors with disorders of anxiety and depression. On 
the other hand, anxiety and depression are also known to 
increase the risk of obesity. Such a mutually reinforcing 
relation can contribute to the association between anxiety 
and depression and coronary artery disease.5
 Mothers with symptoms of anxiety and depression 
and their offspring tend to have similar neuroendocrine 
biomarkers, such as altered levels of cortisol, peripheral 
levels of dopamine and serotonin, right frontal 
electroencephalogram activation and vagal tone.6 If a 
description of specific subgroups, such as patients that 
associate certain biomarkers with specific symptoms, based 
on such data was to emerge, then, both short and long 
term benefits of treatment could potentially be improved. 
Although new reports about treatment response in multisite 
studies have emerged in the past five years, treatment 
advances are lagging due to scarcity of adequate studies 
with the appropriate indicators of response.5 
 Neuroendocrine biomarkers, such as those currently 
associated with the future development of symptoms of 
anxiety and depression, seem more frequent in individuals 
coming from families characterized by intense anxiety and 
depression.2 Moreover, boys and girls living in such families 
may show differences in their vulnerability to develop 
symptoms of anxiety and depression themselves. Therefore 
it is important to take into account the mental state of family 
members, family functioning and the child’s gender, when 
investigating potential neuroendocrine biomarkers for future 
anxiety and depression symptoms as found with obesity.
 Most strategies for the prevention of childhood obesity 
are focused on energy balance.7 They are directed at 
behaviours and environments that directly affect energy 
intake or expenditure, such as increasing physical activity, 
reducing sedentary behaviour, or limiting intake of high 
energy foods and beverages.8 However, the limited 
success of these strategies9-11 underscores the importance 
of developing new approaches through identifying other 
barriers to successful public health strategies.
 Given the current state of knowledge, it is reasonable 
to assume that internalizing symptoms, such as those 
found with anxiety and depression, may be risk factors for 
obesity in children.12-14 Moreover, it also seems sound and 
acceptable to consider that obesity be mediated through 
effects on appetite, sleep, and activity.12-14 The (re)activity 
of the hypothalamic–pituitary–adrenal (HPA)-system plays 
a role in the course of disorders of anxiety and depression. 
In the few studies that have investigated the association 
between anxiety disorders and cortisol levels in children 
and adolescents, findings have been as inconclusive as in 
adults. Del Giudice and Shirtcliff6 hypothesized that stressful 
influences in early life may be associated with higher basal 
levels of cortisol and hyper-responsiveness to subsequent 
minor stressors provoke frequent elevations in cortisol. 
The resulting periods of high levels of cortisol are further 
hypothesized to lead to down-regulation of components of 
the HPA-system. Another possibility is that under repeated 
stress, the initial cortisol response becomes modified over 
the years, so that initial high responses subsequently 
become lower.15 Based on both these possibilities, and 
on the assumption that long periods of stress in early life 
would also predispose to future vulnerability for anxiety, we 
infer that anxiety disorders can be expected to appear in 
association with lower basal cortisol levels. 
 Given the current lack of information about causal 
processes leading to the major health risks associated with 
both anxiety and depression, and obesity, further research 
is needed to facilitate the development of both testable 
hypotheses and the future research agenda. This study 
aims to explore associations between cortisol levels and 
symptoms of anxiety and depression in obese children. 
We hypothesize that gender and family functioning, as 
characterized by different levels of cohesion and adaptability, 
play a role together with cortisol levels and symptoms of 
anxiety and depression in obesity. We also considered 
whether parental mental state could be associated with 
family functioning and cortisol levels in obese children.
MATERIAL AND METHODS
 A sample of children attending the Childhood Obesity 
Paediatric Unit of a tertiary paediatric hospital in Greater 
Lisbon, was drawn from pre-pubertal obese children 
recruited for the project Roots of Early Obesity.16 The 
effective sample was based on the children for whom 
we had detailed records of anthropometric information 
and behavioural measurements throughout childhood. 
Exclusion criteria were the use of medication, having 
already reached puberty during the period of assessment, 
undergoing mental health intervention or other medical 
treatment besides those for obesity.
 Anxiety and depressive symptoms were assessed using 
Anxiety, Depression and Stress Scales (EADS) such as 
‘EADS-C – Escala de Ansiedade, depressão e stresse para 
crianças’, child-version; and ‘EADS - Escala de Ansiedade, 
depressão e stresse’, adult-version. EADS-C and EADS 
are self-report questionnaires validated for Portugal.17,18 
The EADS-C and EADS are a set of three self-reported 
scales (21-items) designed to measure symptoms of 
depression (dysphoria, hopelessness, devaluation of life, 
self-depreciation, lack of interest/involvement, anhedonia, 
and inertia), anxiety (autonomic arousal, skeletal muscle 
effects, situational anxiety, and feeling anxious) and 
stress (difficulty relaxing, hypervigilant, and being easily 
upset/agitated, irritable/over-reactive and impatient). The 
responses are classified according to four levels: 0) never 
happens; 1) happens sometimes; 2) happens very often; 
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similar to the adult version18 although the load values of 
the items in each dimension are less discriminative than in 
adults.17 
 The Child Behaviour Checklist (CBCL 6 ‒ 18) is a 
parent-reported questionnaire for assessing behavioural 
or emotional problems in children and adolescents (aged 
6 to 18 year olds). It contains 120 items on behavioural or 
emotional problems experienced in the six months prior to 
the test. These items are scored on a three point scale: 0 = 
not true; 1 = somewhat or sometimes true; 2 = very or often 
true. 
 The CBCL version used is approved by Achenbach 
(http://www.aseba.org/ordering/translations.html).19 
This instrument is used to explore internalizing and 
externalizing symptoms. As conceived by Achenbach 
(1991), internalizing symptoms refer to three categories: 
withdrawal, somatic complaints, and anxiety/depression. 
Externalizing symptoms refer to the categories of delinquent 
and aggressive behaviour.
 Family functioning was assessed using Family 
Adaptation and Cohesion Scales (FACES) III,20 a parent-
reported questionnaire, validated for Portugal.20 Only one 
parent per child participated, most often the mother. This 
self-reported 20-item Lykert type questionnaire evaluates 
two major dimensions (Cohesion and Family Adaptation) on 
a circumplex model, which is integral to the conceptualisation 
of functioning employed in FACES. Reliability for Cohesion 
is 0.78 and for Family Adaptation is 0.70.20 
 Cohesion is conceptualised as the emotional closeness 
that family members have to one another. Adaptability 
is conceptualised as the potential for change in family 
leadership, role relationship, and relationship rules. FACES 
assesses the degree to which family members are adaptive 
and connected to each other. The dimension of family 
adaptability is categorised into four ‘levels’ of functioning: 
rigid, structured, flexible, and chaotic. The two middle levels 
(structured and flexible) are considered as balanced family 
adaptability and the two extreme levels (rigid and chaotic) 
are considered as unbalanced levels of family adaptability. 
The dimension of family cohesion is categorised into four 
‘levels’ of functioning: disengaged, separated, connected, 
and enmeshed. Similar to that for family adaptability, 
the two middle levels (separated and connected) are 
considered to be balanced levels of family cohesion and 
the two extreme levels (disengaged and enmeshed) are 
considered to be unbalanced levels of family cohesion.20 In 
other words, balanced levels of cohesion and adaptability 
are conceptualised as reflecting healthier family functioning, 
and they are classified as ‘high functioning families’. 
Unbalanced levels of cohesion and adaptability (very low 
or very high levels) are seen as reflecting more problematic 
family functioning, and they are classified as ‘low functioning 
families’.
 Height, weight, waist circumference, blood pressure and 
heart rate were measured following standardized protocols. 
Obesity was defined as BMI (kg.m-2) above the 95th age - 
and gender-specific percentile.21 Overweight was defined 
as BMI (kg.m-2) above the 85th age- and gender-specific 
percentile.21 Blood pressure was measured three times and 
the third reading was recorded.21 Age and gender-specific 
percentiles were used.21
 As part of the Roots of Early Obesity project,16 
fasting blood samples were drawn at 8 a.m. through an 
indwelling catheter, after 45 minuntes of rest. Plasma 
cortisol, glucose, insulin, high density lipoprotein (HDL) 
and low density lipoprotein (LDL) cholesterol, triglycerides 
and catecholamines were measured using the standard 
procedures of the Clinical Pathology Laboratory of the 
institution. 
 Parental written, informed consent was obtained. 
The project was approved by the Hospital Medical Ethics 
Committee.
 To investigate the nature of the relation between cortisol 
levels, and symptoms of anxiety and depression (modelled 
as ordinal variables), Spearman correlation analyses 
and significance tests were performed, both with respect 
to the global sample and to each of its above mentioned 
subgroups.21 Data analysis was performed using the 
software SPSS 22.0.22
RESULTS
 A sample of 104 recruited pre-pubertal children (55 
boys), with mean age of 10.88 years (standard deviation 
1.76) was included in the analysis. BMI was calculated for 
63 children, of whom 59 were obese (35 boys) and four 
were overweight (one boy). Waist circumference was 
measured in 46 children, with median (P25 - P75) of 90.5 cm 
(76.8 – 97.1). Hypertension was diagnosed in 13 out of 59 
assessed children.
 The values found for the symptom scores (anxiety, 
depression and internalizing symptoms, which included 
anxiety and depression in Achenbach’s CBCL system) and 
Table 1 - Symptom scores (anxiety, depression and internalizing 
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neuroendocrine and metabolic biomarkers in the complete 
sample are presented as Tables 1 and 2. 
 The distribution of symptom scores and serum cortisol 
levels in the whole sample showed no significant differences 
between either high and low functioning families, or 
between boys and girls, but the score (median, P25 - P75) 
for internalizing symptoms (CBCL) showed a tendency 
to be higher in boys (12.5, 9.0 - 15.0 vs 9.0, 6.5 - 13.5; 
Mann-Whitney, p = 0.066) (see also Table 3). An interesting 
observation, which nevertheless lead to no changes in 
cortisol, was that parents of obese boys scored (median, 
P25 - P75) markedly higher, as close to significance as it is 
possible to get, for depression symptoms (EADS) compared 
to parents of obese girls (28, 10 - 66 vs 10, 0-38; Mann-
Whitney, p = 0.051).
 Serum cortisol levels in girls had a significant (p = 0.026) 
but low (rs = -0.464) negative correlation with parent-reported 
anxiety score (EADS) (Table 4). Nearly significant negative 
low correlations were found between serum cortisol levels 
and parent-reported anxiety score (EADS) in children 
from low functioning families, child-reported anxiety score 
(EADS-C) in children from high functioning families and the 
score for externalizing symptoms (CBCL) in girls (Table 4). 
 The distribution of symptom scores and cortisol levels 
according to gender and family functioning is presented 
in Table 1. Girls from low functioning families scored 
significantly lower for internalizing problems (CBCL) than 
boys from both high (Kruskal-Wallis, p = 0.039) and low 
(Kruskal-Wallis, p = 0.018) functioning families but scored 
similarly to females from high functioning families (Table 3). 
No significant differences were found when considering BMI 
categories.
 Table 5 shows the results for the correlation analyses 
and significance tests between serum cortisol levels and 
symptom scores (anxiety, depression, internalizing and 
externalizing symptoms), for each of the four subgroups 
(according to gender and family functioning). There was 
a significant, negative correlation between obese girls’ 
cortisol and their parents’ self-reported anxiety symptoms 
limited to high functioning families (rs = -0.779; p = 0.003). 
No association was found between child serum cortisol and 
parental self-reported depressive symptoms.
DISCUSSION
 This study explores associations between basal serum 
cortisol levels and symptoms of anxiety and depression in a 
sample of obese children. We found a significant negative 
association between serum cortisol and the parents’ anxiety 
symptoms, limited to girls and particularly significant for girls 
from high functioning families. Boys scored significantly 
higher for parent-reported internalizing symptoms than 
girls. Parents of obese boys scored markedly higher for 
symptoms of depression than parents of obese girls. No 
associations were found between the children’s serum 
cortisol and their parents’ depressive symptoms, indicating 
that the association that was found between serum cortisol 
and parents’ anxiety symptoms was specific for anxiety.
 One possible explanation for this association between 
parents’ anxiety symptoms and children’s cortisol levels 
is that it is secondary to alterations in HPA-system activity 
present from birth. HPA-system functioning is at least 
partially determined by genetic23,24 and prenatal factors.25 
For example, corticotrophic releasing hormone (CRH) 
gene regulation involves multiple activating and repressing 
Table 2 - Descriptives of the neuroendocrine and metabolic biomarkers values
Parameter (n) Mean (SD) Median Min. - Max. P25 - P75
Glucose (mg/dL) (57) 92.5 (15.4) 93.0 1 - 120 89.0 - 98.0
Insulin (U/mL) (43) 14.55 (9.60) 13.4 0.28 - 52.95 7.99 - 16.92
Triglycerides (mg/dL) (51) 97.21 (39.80) 89.0 33 - 187 68.0 - 129.0
Cholesterol (mg/dL) (53) 161.85 (31.00) 166.0 49 - 227 145.0 - 184.0
HDL (mg/dL) (50) 48.80 (13.87) 47.0 24 - 91 38.0 - 57.3
LDL (mg/dL) (48) 107.93 (23.51) 109.5 59 - 167 95.0 - 118.5
ALT (U/L) (50) 28.20 (23.42) 23.0 11 - 167 17.0 - 30.0
AST (U/L) (48) 24.10 (7.44) 24.5 12 - 56 19.0 - 26.8
TSH (µIU/mL) (56) 2.74 (1.17) 2.6 0.72 - 5.92 1.8 - 3.5
T4 (ng/dL) (53) 1.27 (2.11) 1.0 0.59 - 16.20 0.8 - 1.2
ACTH (pg/mL) (68) 28.89 (20.67) 20.7 5.35 - 118.0 16.3 - 35.2
Cortisol(µg/dL) (53) 10.8 (5.16) 9.95 3.3 - 29.0 7.2 - 13.6
Dopamine urine (µg/dL) (18) 236.8 (128.07) 236.8 45.0 - 513.8 145.6 - 348.4
Dopamine plasma (µg/dL) (12) 115.6 (150.40) 37.3 6.0 - 510.96 24.8 - 205.40
Epinephrine urine (µg/dL) (17) 6.7 (7.36) 5.99 0.5 - 32.5 3.5 - 7.65
Epinephrine plasma(µg/dL) (12) 5.4 (9.66) 0.7 0.09 - 32.5 0.4 - 6.8
Norepinephrine urine(µg/dL) (17) 34.2 (25.46) 30.7 5.9 - 105.8 17.5 - 47.7
Norepinephrine plasma(µg/dL)(12) 15.8 (23.47) 5.8 0.8 - 81.4 2.4 - 19.1
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transcription factors, specifically the glucocorticoid receptors 
and cyclic adenosine monophosphate (cAMP). Another 
important biological aspect is timing in the transcription of 
the signals, which is critical for effective glucocorticoid (GC) 
repression of the cAMP induced CRH gene.24 Therefore, 
differences in timing of stimulatory and repression signals 
may be important for adaptation of the organism to stress, 
thereby providing a molecular explanation for the variability 
in adaptation to stress. These factors may influence CRH 
secretion patterns,26 feedback effects of cortisol on central 
GC receptors, or both.24 
 On theoretical grounds, one can expect alterations in 
HPA-system activity to be more evident in individuals with 
a long history of anxiety symptoms. These changes may 
be reasonably interpreted as expressing a state of accrued 
vulnerability which is akin to some increment in maternal 
stress, in particular, during the latter half of pregnancy. Such 
undesirable conditions are known to favour maternal weight 
gain during pregnancy.27 An overactive HPA-system leading 
to elevated cortisol levels is associated with an increased 
prevalence of abdominal obesity, although previous 
studies have suggested that there are obese individuals 
who may have desensitization to glucocorticoids, thereby 
not exhibiting increased blood cortisol.24 A well accepted 
hypothesis is that once the HPA-system is over-activated 
during early development, it remains permanently unstable, 
vulnerable or dysfunctional, possibly due to transcriptional/
epigenomic mechanisms.28
 These elevations could influence down-regulation of 
components of the HPA-system, as suggested by the 
Adaptive Calibration Model,6 an evolutionary-developmental 
theory of individual differences in the functioning of the 
stress response system. HPA activity is regulated by a 
hierarchy of feedback loops at different levels in the axis, 
and the sensitivity of these feedback loops is a major factor 
in determining HPA responsivity. The HPA-system responds 
to chronic stressors with sustained cortisol elevation, 
resulting in a flattened diurnal rhythm of secretion. Chronic 
elevation is often followed by a negative rebound of the 
system to below the previous baseline level after the 
stressor terminates. This hypocortisolism phase can last 
months; its function is probably to facilitate recovery and 
offset the physiological and immune costs of high circulating 
cortisol.6 Hence, high and persistent levels of anxiety could 
Table 3 - Symptom scores (anxiety, depression and internalizing symptoms) and cortisol levels as median (P25 - P75), according to gender 
and family functioning
Measures
High functioning family Low functioning family                         
Boys Girls Boys Girls
EADS 
Anxiety symptoms
10.0 (2.0 - 21.8)
n = 18
7.0 (2.0 - 17.5)
n = 17
14.0 (10.0 - 19.0)
n = 11




14.0 (4.5 - 32.3)
n = 18
17.0 (2.5 - 24.0)
n = 17
14.0 (6.0 - 21.0)
n = 11




12.0 (9.5 - 14.5)
n = 17
11.0 (8.0 - 16.0)
n = 15
14.0 (9.0 - 22.0) 
n = 10
5.0 (2.0 - 7.5) 
n = 5
Cortisol (ug/dL) 8.5 (6.7 - 11.7)
n = 14
10.6 (6.8 - 13.0)
n = 13
11.2 (8.8 - 16.8)
n = 9
15.2 (5.8 - 17.5) 
n = 4
EADS: Escala de ansiedade, depressão e stresse, adult version; CBCL: Child Behaviour Checklist
Table 4 - Correlation of cortisol levels (ug/L) with anxiety, depression, internalizing and externalizing symptoms, for each subgroup of the 
sample
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be associated with low cortisol concentrations, reflecting 
resilience rather than a risk for psychopathology.29
 This is in accordance with the present study´s findings 
for girls. We found a significant negative association 
between serum cortisol and parents’ anxiety symptoms, 
limited to girls, and particularly significant for girls from high 
functioning families. 
 Family functioning might operate through either a 
threshold effect, or be secondary to reduced buffering 
effects of protective relationships.7 Possibly parents with 
high levels of anxiety symptoms influence their children’s 
vulnerability to anxiety symptoms through an excess of 
control. In fact, some overprotective parenting behaviour has 
been associated with increased risk for anxiety symptoms in 
children.30,31 In the group from low functioning families, the 
association between parents’ anxiety symptoms and cortisol 
was not found to be statistically significant. However, this 
limitation may well be just a reflection of the small sample 
sizes of children for whom complete data-sets were obtained 
(Table 5). It is also proposed that affects are ‘infectious’ – 
and mirror neurone influences may be at play so that the 
affective state of the parent is contagious. We already 
know that successful treatment of a depressive disorder in 
adolescents depends on treating any concomitant parental 
depressive disorder at the same time. But we are unaware 
of studies having looked at the same for anxiety.
 There is another possibility to explain the slightly 
paradoxical finding of a relationship between higher 
functioning, parental anxiety symptoms and girls’ cortisol. 
The findings depend on self-reports from the parents, and 
it may be that parents from lower functioning families, 
particularly those high on rigidity and disengaged, are less 
clear about reporting on their subjective affective states. 
The relation between family functioning and quality of 
the self-reported information needs further investigation. 
Nevertheless there is a definite relation between parental 
mental state and biomarkers in their children. Future 
research needs to look at whether there is a connection 
between parental mental state, parental awareness of 
their children’s diverse forms of distress, including those 
of anxiety and depression, and family functioning. The 
finding about lower reporting of internalizing symptoms in 
girls from low functioning families, may also be a result of 
lower parental awareness of their daughters’ subjective 
discomforts, rather than an absolute finding that these girls 
had actually less internalizing distress. Parents of obese 
boys scored markedly higher for symptoms of depression 
than parents of obese girls.
 On the other hand, investigating the role of genetic, 
epigenetic, attachment strategies and their interactions 
was beyond the scope of the present study. The role of 
attachment strategies is addressed elsewhere.32
 The areas of the brain that govern energy balance are 
also involved in the response to stress and in emotion 
regulation. Extreme and/or sustained stress is associated 
with disregulation of energy balance.13,28,33 Protection 
against obesity may arise by improving children’s ability 
to modulate their metabolic and behavioural responses to 
stress. Thus educated, they would be able to read their 
body signals, both implicit and explicit, and use the signals 
more appropriately to achieve a greater state of well-being, 
harnessing their needs. Children whose stress response is 
well regulated may be less likely, for example, to overeat in 
response to emotional distress, and may have longer sleep 
duration, which could also reduce their risk for obesity.29,34
Strengths and limitations
 Our goal was to contribute to understand the complexity 
Table 5 - Rank correlation analyses between serum cortisol levels and symptom scores (anxiety, depression, internalizing and externalizing 
symptoms), for each subgroups (according to gender and family functioning) of the sample
High functioning family Low functioning family
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of a wide range of associations with cortisol levels in obese 
children. The study was not designed to test hypotheses, 
include all possible relevant parameters or be designed to 
generalize the findings to other samples. Through identifying 
discrete subsamples it may be possible to identify factors 
that only have effects under limited circumstances. But our 
study size means that such subsamples were of necessity 
very small.
 In this study, HPA-system activity was not directly 
assessed in response to a stressor. The results do not reflect 
absolute changes in cortisol levels but shifts in the diurnal 
rhythm which itself might not be constant when there is 
anxiety or depression. Thus, future studies that assess both 
measures simultaneously may reveal more differentiated, 
results. The ethical dilemma arise with exposing children 
to prospective stress, and it may be that one would have to 
be limited to such situations as arise with starting at a new 
school or similar. 
 The findings depend on self-reports primarily from 
the mothers, rather than both parents, and it may be that 
parents from lower functioning families are less clear about 
reporting on their subjective affective states. The FACES 
dimensions suggest different forms of low functioning, ie low 
in quality, but including dimensionally opposite extremes. 
The study cannot elaborate on this. Within the attachment 
paradigm we would expect the outliers to be a mixture of 
those who overemphasise their discomforts (Type C), and 
those who have always displayed little of their affective 
states, and been poorly aware of what they might be (Type 
A). The relation between family functioning and quality of 
the self-reported information underlines the importance 
of using multiple sources providing both self-report and 
observations, also while investigating neuroendocrine 
biomarkers of anxiety and depression.35 
 If specific subgroups based on patients in whom there 
are different associations between biomarkers and specific 
symptoms emerges, then, both short and long term benefits 
of treatment could potentially be improved.
 Due to the exploratory nature of this project, it was only 
possible to identify a few discrete subsamples from which it 
seems possible to gain further insight into the role of factors 
that under certain circumstances contribute to the symptom 
constellation.
CONCLUSION
 These results highlight the importance of taking into 
account family functioning, parental mental state and 
gender, when investigating neuroendocrine biomarkers 
associated with symptoms of anxiety and depression in 
obese children. We present empirical evidence that the 
harnessing of such a complex, mutually reinforcing dynamic 
across generations may open the way to the identification of 
relevant neuroendocrine biomarkers and, thereby, open the 
horizon for the design of effective preventive strategies.
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